About
Omri Amirav-Drory, Ph.D., is General Partner and Head of NFX Bio, where he backs early-stage techbio companies. He previously founded Genome Compiler, which was acquired by Twist Bioscience, and later served in corporate development at Twist. He is also the founding CEO/partner behind Tech.Bio and serves on boards including ImmuneBridge.
Areas of interest
biotechtechbiosynthetic biologydrug discoverygenerative AIlongevityscientist-foundersbioeconomy